MAPRE3 and colorectal carcinoma: The Bastian laboratory showed that chromosomally instable (CIN+) colorectal cancer (CRC) cells have increased microtubule plus-end growth, compared to nontumorous RPE1 and CIN− CRC cells, as shown by the microtubule plus-end protein EB3 tracking in space and time.